Autopsy report · NCT02387164

Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies

“The study was interrupted early and terminated when only 26 out of 80 patients were enrolled due to new clinical study results indicating that the current study would not be informative.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 years 7 months before it stopped.
• 26 participants enrolled.
• Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Lund University

Sponsor type

University, hospital or other

Conditions

Diabetes Mellitus, Type 1; Prediabetic State

Interventions

Alum-GAD; Vitamin D3

Participants

26

Sites

1

Countries

Sweden

Trials that died the same way

• Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
  “The study was stopped due to difficulties in including patients” (79% match in meaning)
• Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.
  “The study was terminated early due to the inability to recruit the planned number of patients” (78% match in meaning)
• Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
  “The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the investigational treatments have been moved to a continuation study (NCT05059522)” (78% match in meaning)
• Phase II Study of TAEST16001 in Soft Tissue Sarcoma
  “The study was terminated due to initiation of a new clinical trial with an updated study design.” (78% match in meaning)
• GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line
  “Study was terminated due to positive results seen in statistical analysis. Adequate patient enrollment was achieved.” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.